Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), CVS Health (CVS) and Tempest Therapeutics (TPST)
Express News | US Jury Finds Abbott's Premature Infant Formula Caused Girl's Dangerous Bowel Disease, Awards Mother $95 Mln in Compensatory Damages
Abbott Laboratories's Options Frenzy: What You Need to Know
DexCom Stock Plunges Following Guidance Cut; Results 'Disappointing', Oppenheimer Says
Peering Into Abbott Laboratories's Recent Short Interest
ICON (ICLR) Q2 Earnings Surpass Estimates, Margins Expand
Better Buy: Abbott Laboratories Vs. Intuitive Surgical
Behind the Scenes of Abbott Laboratories's Latest Options Trends
S&P 500's Biggest Loser Has a Heart Valve Problem -- WSJ
Express News | Abbott - Correction Impacts a Small Subset of Freestyle Libre 3 Sensors From Among Those Within Three Lots in the U.S. Only
Express News | Abbott Issues Voluntary Medical Device Correction for a Small Number of Freestyle Libre® 3 Sensors in the U.S.
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
Daiwa Securities Adjusts Price Target on Abbott Laboratories to $120 From $125
Abbott Laboratories (ABT) Is Attracting Investor Attention: Here Is What You Should Know
Here's Why Aristotle Atlantic's Core Equity Composite Sold Abbott Laboratories (ABT)
Abbott Issues Voluntary Medical Device Correction for a Small Number of FreeStyle Libre 3 Sensors in the U.S.
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Morgan Stanley Maintains Abbott Laboratories(ABT.US) With Hold Rating, Maintains Target Price $107